Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pathologic Evaluation of Therapeutic Biomarkers in Colorectal Adenocarcinoma.

Surgical pathology clinics - 1 Dec 2023

Baranov Esther, Nowak Jonathan A

Abstract excerpt

Molecular testing is an essential component of the pathologic evaluation of colorectal carcinoma providing diagnostic, prognostic, and predictive therapeutic information. Mismatch repair status evaluation is required for all tumors. Advanced and metastatic tumors also require determination of tumor mutational burden, KRAS, NRAS, and BRAF mutation status, ERBB2 amplification status, and NTRK and RET gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Biomarkers, Tumor
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mismatch Repair

Share to Microsatellite Instability

Share to Mutation

Share to Prognosis

Share to Proto-Oncogene Proteins B-raf

Source

Identifiers

PMID: 37863556
DOI: 10.1016/j.path.2023.05.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pathologic Evaluation of Therapeutic Biomarkers in Colorectal Adenocarcinoma.PMID 37863556Read ↗

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.Semantic proximity Read ↗

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.Semantic proximity Read ↗

Comprehensive Landscape of Diagnostic, Prognostic and Predictive Biomarkers in Colorectal Cancer: From Genomics to Multi-Omics Integration in Precision MedicineSemantic proximity Read ↗

Translating colorectal cancer genetics into clinically useful biomarkers.Semantic proximity Read ↗

Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer: an update.Semantic proximity Read ↗

Current and future biomarkers in colorectal cancerSemantic proximity Read ↗

Practical and molecular evaluation of colorectal cancer: new roles for the pathologist in the era of targeted therapy.Semantic proximity Read ↗

Precision Medicine in Colorectal Cancer: Evolving Genomic Landscape and Emerging ConsensusSemantic proximity Read ↗

New Guideline on Managing Colorectal Cancer.Semantic proximity Read ↗

Japanese Society of Medical Oncology clinical guidelines: Molecular testing for colorectal cancer treatment, 5th edition.Semantic proximity Read ↗

Agnostic Biomarkers and Molecular Signatures in Colorectal Cancer—Guiding Chemotherapy and Predicting ResponseSemantic proximity Read ↗

Epidermal growth factor receptor pathway mutations and colorectal cancer therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.